# Delivery Order #SPE2D326F122K

Pfizer Delivery Order for Lidocaine Injection

**Buyer:** Defense Logistics Agency

**Award Amount:** $100.00
**Ceiling:** $100.00

**Awarded:** May 14, 2026
**Period of Performance:** May 14, 2026 - May 15, 2026

**Identifier:** SPE2D326F122K
**NAICS:** 325412

This delivery order under a Department of Defense indefinite-delivery contract with Pfizer Inc. procures 2% lidocaine hydrochloride in 20 mL vials, an injectable medicine used for local anesthesia. It supports military medical supply needs by providing a pharmaceutical product for clinical care. The order covers a brief delivery period and identifies New York, New York, as the place of performance. The parent contract is a long-term pharmaceutical supply vehicle running through 2030 and was described as competitively awarded. The order-level data does not specify its own competition method, solicitation, acquisition program, or subcontractors; no previous order-level performance is provided.

### Description

4571834068!LIDOCAINE HCL 2% VIAL 20ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F122K_9700_SPE2D020D0014_9700)
